Figure_2.tif (418.37 kB)
Mean plasma ozanezumab concentration-time profiles following single (A) or two (B) IV infusions of ozanezumab.
figure
posted on 2014-05-19, 03:05 authored by Vincent Meininger, Pierre-François Pradat, Andrea Corse, Safa Al-Sarraj, Benjamin Rix Brooks, James B. Caress, Merit Cudkowicz, Stephen J. Kolb, Dale Lange, P. Nigel Leigh, Thomas Meyer, Stefano Milleri, Karen E. Morrison, Richard W. Orrell, Gary Peters, Jeffrey D. Rothstein, Jeremy Shefner, Arseniy Lavrov, Nicola Williams, Phil Overend, Jeffrey Price, Stewart Bates, Jonathan Bullman, David Krull, Alienor Berges, Bams Abila, Guy Meno-Tetang, Jens WurthnerMean plasma ozanezumab concentration-time profiles following single (A) or two (B) IV infusions of ozanezumab.
History
Usage metrics
Categories
Keywords
anatomyMusculoskeletal systemimmunologyClinical immunologyimmunotherapyimmunityClinical medicineclinical trialsneurologyNeurodegenerative diseasesMotor neuron diseasesamyotrophic lateral sclerosispharmacologyAdverse reactionspharmacokineticsresearch designClinical research designplasmaozanezumabconcentration-timeprofilesivinfusions
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC